Heather Kidwell - ZimVie Chief VP
| ZIMV Stock | USD 14.53 0.01 0.07% |
Insider
Heather Kidwell is Chief VP of ZimVie Inc
| Age | 55 |
| Address | 4555 Riverside Drive, Palm Beach Gardens, FL, United States, 33410 |
| Phone | 303 443 7500 |
| Web | https://www.zimvie.com |
Heather Kidwell Latest Insider Activity
Tracking and analyzing the buying and selling activities of Heather Kidwell against ZimVie stock is an integral part of due diligence when investing in ZimVie. Heather Kidwell insider activity provides valuable insight into whether ZimVie is net buyers or sellers over its current business cycle. Note, ZimVie insiders must abide by specific rules, including filing SEC forms every time they buy or sell ZimVie'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Heather Kidwell over two months ago Acquisition by Heather Kidwell of 24190 shares of ZimVie subject to Rule 16b-3 |
ZimVie Management Efficiency
Return On Tangible Assets is likely to climb to -0.45 in 2024. Return On Capital Employed is likely to drop to -0.03 in 2024. At this time, ZimVie's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 981.2 M in 2024, whereas Other Current Assets are likely to drop slightly above 142.4 M in 2024. ZimVie's management efficiency ratios could be used to measure how well ZimVie manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Robert Cohen | Stryker | N/A | |
| Jean Holloway | Artivion | 63 | |
| Geoffrey Rose | Pulmonx Corp | 50 | |
| Mark Quick | Orthofix Medical | N/A | |
| Mark Saxton | Neuropace | 59 | |
| Peter Coenen | Smith Nephew SNATS | 59 | |
| Sri Radhakrishnan | Pulmonx Corp | N/A | |
| Paul Verrastro | CVRx Inc | 61 | |
| Derrick Sung | Pulmonx Corp | 51 | |
| Andrew Pierce | Stryker | 50 | |
| Myra Eskes | Smith Nephew SNATS | 49 | |
| Michael Favet | Neuropace | 54 | |
| Joshua Wells | Artivion | N/A | |
| John Davis | Artivion | 59 | |
| John McKune | Pulmonx Corp | 48 | |
| Jon Salveson | Artivion | 56 | |
| Lauren Cristina | Pulmonx Corp | N/A | |
| Rebecca Kuhn | Neuropace | 63 | |
| Ehab Esmail | Orthofix Medical | 52 | |
| Laura MBA | Si Bone | 57 | |
| Laverne Council | CONMED | 59 | |
Management Performance
| Return On Equity | -0.0855 | ||||
| Return On Asset | -0.005 |
ZimVie Inc Leadership Team
Elected by the shareholders, the ZimVie's board of directors comprises two types of representatives: ZimVie inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ZimVie. The board's role is to monitor ZimVie's management team and ensure that shareholders' interests are well served. ZimVie's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ZimVie's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Indraneel Kanaglekar, Senior Officer | ||
| Benjamin Hutson, VP Operations | ||
| Steve Rondeau, Senior Officer | ||
| Vafa Jamali, CEO President | ||
| Michael Minette, Sr Devel | ||
| Ann Vu, Quality Affairs | ||
| Rebecca Whitney, Senior Spine | ||
| Sandra Schneider, Chief Officer | ||
| Laura Driscoll, Vice Communications | ||
| Richard Heppenstall, CFO VP | ||
| Heather Kidwell, Chief VP |
ZimVie Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ZimVie a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0855 | ||||
| Return On Asset | -0.005 | ||||
| Profit Margin | (0.77) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 568.4 M | ||||
| Shares Outstanding | 27.6 M | ||||
| Shares Owned By Insiders | 1.93 % | ||||
| Shares Owned By Institutions | 91.95 % | ||||
| Number Of Shares Shorted | 325.13 K | ||||
| Price To Book | 0.99 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ZimVie Stock Analysis
When running ZimVie's price analysis, check to measure ZimVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ZimVie is operating at the current time. Most of ZimVie's value examination focuses on studying past and present price action to predict the probability of ZimVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ZimVie's price. Additionally, you may evaluate how the addition of ZimVie to your portfolios can decrease your overall portfolio volatility.